SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (6944)6/6/2003 3:02:34 AM
From: Icebrg  Read Replies (1) of 10280
 
Thanks Jon

I am disappointed that that has slipped through my keyboard. The distinguishing factors for both ESTORRA and Indiplon MR (I own both NBIX and SEPR, so I prefer that perspective) is that both products claim to offer full night "medication" without next-day side-effects. This might still turn out to be a competitive advantage. Meanwhile, I will see what I can dig out about the drug.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News